Evidence map›Paper›PMID 42360589›Full record

ArticleDermatology and therapy2026

A Response to: "Letter to the Editor Regarding 'Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis'".

Matthias Augustin, April W Armstrong, Naiem T Issa, Anne Sohrt Petersen, Rie von Eyben, Teodora Festini, Tiago Torres

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Dermatology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Matthias AugustinInstitute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany. m.augustin@uke.de.ORCID http://orcid.org/0000-0002-4026-8728
April W ArmstrongDavid Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Naiem T IssaForefront Dermatology, Vienna, VA, USA.
Anne Sohrt PetersenLEO Pharma A/S, Ballerup, Denmark.
Rie von EybenLEO Pharma A/S, Ballerup, Denmark.
Teodora FestiniLEO Pharma A/S, Ballerup, Denmark.
Tiago TorresInstituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Atopic dermatitisLebrikizumabLong-term disease managementMaintenance of efficacyMatching-adjusted indirect comparisonTralokinumab

Identifiers

PMID42360589
PMCPMC13493355

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.